Health Awareness, Inc   Report issue

For profit Phase 2 Phase 3
Founded: Jupiter FL United States (1999)

Organization Overview

First Clinical Trial
2014
NCT02195986
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Health Awareness, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophic Vaginitis (Phase 3)

Atrophy (Phase 3)

Hypertension (Phase 2)

Vaginitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 6